Myriad Genetics Inc Q4 FY2019 Earnings Call

Myriad Genetics Inc (MYGN)

Earnings Call FY2019 Q4 Call date: 2020-02-06 Concluded

Quarter scorecard

Revenue

$195.10M

-10% YoY

Diluted EPS

$-0.11

-466.7% YoY

Net income

-$8.30M

-419.2% YoY

Diagnostics $177.60M

-12.5%

All Other Segments $17.50M

+26.8%